HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol

Clinical outcomes and messenger RNA profiles

Thangamani Muthukumar, Cheguevara Afaneh, Ruchuang Ding, Demetra Tsapepas, Michelle Lubetzky, Samantha Jacobs, John Lee, Vijay Sharma, Jun Lee, Darshana Dadhania, Choli Hartono, Jennifer McDermott, Meredith Aull, David Leeser, Sandip Kapur, David Serur, Manikkam Suthanthiran

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background. The outcome of HIV-infected kidney transplant recipients managed with an early corticosteroid withdrawal protocol is not known. Methods. Eleven consecutive HIV-infected patients with undetectable plasma HIV RNA and more than 200/mm3 CD4+ T cells underwent deceased-donor (n=8) or living-donor (n=3) kidney transplantation at our center. All were managed with an early corticosteroid withdrawal protocol; 9 of 11 received antithymocyte globulin and 2 received basiliximab induction. We analyzed patient and graft outcomes, acute rejection rate, HIV progression, BKV replication, infections, and urinary cell mRNA profiles. Results. The median (range) follow-up was 44.5 (26Y73) months. The incidence of acute rejection was 9% at 1 year and the patient and allograft survival rates were 100% and 91%, respectively. Estimated glomerular filtration rate at 1 year (meanTSD) was 78T39 mL/min/1.73 m2. Plasma HIV RNA was undetectable at 24 months and none had BKV replication. Six of the 11 kidney recipients developed eight infections requiring hospitalization. Urinary cell levels of mRNA for complement components and complement regulatory proteins, cell lineageYspecific proteins CD3, CD4, CD8, CTLA4, Foxp3, chemokine IP-10, cytotoxic perforin and granzyme B, and BKV VP1 mRNA were not different (P90.05) between HIV-infected patients and HIV-negative recipients (n=22) with stable graft function and normal biopsy results. Conclusion. An early steroid withdrawal regimen with antithymocyte globulin induction was associated with excellent graft and patient outcomes in HIV-infected recipients of kidney allografts. Their urinary cell mRNA profiles are indistinguishable from those of HIV-negative patients with stable graft function and normal biopsy results.

Original languageEnglish
Pages (from-to)711-720
Number of pages10
JournalTransplantation
Volume95
Issue number5
DOIs
Publication statusPublished - 15 Mar 2013
Externally publishedYes

Fingerprint

Clinical Protocols
Adrenal Cortex Hormones
HIV
Transplants
Kidney
Messenger RNA
Antilymphocyte Serum
Allografts
RNA
Biopsy
Living Donors
Infection
Glomerular Filtration Rate
Chemokines
Kidney Transplantation
Complement System Proteins
Hospitalization
Survival Rate
Steroids
Tissue Donors

Keywords

  • Gene expression
  • HIV
  • Kidney transplantation
  • Tacrolimus

ASJC Scopus subject areas

  • Transplantation

Cite this

HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol : Clinical outcomes and messenger RNA profiles. / Muthukumar, Thangamani; Afaneh, Cheguevara; Ding, Ruchuang; Tsapepas, Demetra; Lubetzky, Michelle; Jacobs, Samantha; Lee, John; Sharma, Vijay; Lee, Jun; Dadhania, Darshana; Hartono, Choli; McDermott, Jennifer; Aull, Meredith; Leeser, David; Kapur, Sandip; Serur, David; Suthanthiran, Manikkam.

In: Transplantation, Vol. 95, No. 5, 15.03.2013, p. 711-720.

Research output: Contribution to journalArticle

Muthukumar, T, Afaneh, C, Ding, R, Tsapepas, D, Lubetzky, M, Jacobs, S, Lee, J, Sharma, V, Lee, J, Dadhania, D, Hartono, C, McDermott, J, Aull, M, Leeser, D, Kapur, S, Serur, D & Suthanthiran, M 2013, 'HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: Clinical outcomes and messenger RNA profiles', Transplantation, vol. 95, no. 5, pp. 711-720. https://doi.org/10.1097/TP.0b013e31827ac322
Muthukumar, Thangamani ; Afaneh, Cheguevara ; Ding, Ruchuang ; Tsapepas, Demetra ; Lubetzky, Michelle ; Jacobs, Samantha ; Lee, John ; Sharma, Vijay ; Lee, Jun ; Dadhania, Darshana ; Hartono, Choli ; McDermott, Jennifer ; Aull, Meredith ; Leeser, David ; Kapur, Sandip ; Serur, David ; Suthanthiran, Manikkam. / HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol : Clinical outcomes and messenger RNA profiles. In: Transplantation. 2013 ; Vol. 95, No. 5. pp. 711-720.
@article{55816c5665c94cbf923f7bdb6cab25b9,
title = "HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: Clinical outcomes and messenger RNA profiles",
abstract = "Background. The outcome of HIV-infected kidney transplant recipients managed with an early corticosteroid withdrawal protocol is not known. Methods. Eleven consecutive HIV-infected patients with undetectable plasma HIV RNA and more than 200/mm3 CD4+ T cells underwent deceased-donor (n=8) or living-donor (n=3) kidney transplantation at our center. All were managed with an early corticosteroid withdrawal protocol; 9 of 11 received antithymocyte globulin and 2 received basiliximab induction. We analyzed patient and graft outcomes, acute rejection rate, HIV progression, BKV replication, infections, and urinary cell mRNA profiles. Results. The median (range) follow-up was 44.5 (26Y73) months. The incidence of acute rejection was 9{\%} at 1 year and the patient and allograft survival rates were 100{\%} and 91{\%}, respectively. Estimated glomerular filtration rate at 1 year (meanTSD) was 78T39 mL/min/1.73 m2. Plasma HIV RNA was undetectable at 24 months and none had BKV replication. Six of the 11 kidney recipients developed eight infections requiring hospitalization. Urinary cell levels of mRNA for complement components and complement regulatory proteins, cell lineageYspecific proteins CD3, CD4, CD8, CTLA4, Foxp3, chemokine IP-10, cytotoxic perforin and granzyme B, and BKV VP1 mRNA were not different (P90.05) between HIV-infected patients and HIV-negative recipients (n=22) with stable graft function and normal biopsy results. Conclusion. An early steroid withdrawal regimen with antithymocyte globulin induction was associated with excellent graft and patient outcomes in HIV-infected recipients of kidney allografts. Their urinary cell mRNA profiles are indistinguishable from those of HIV-negative patients with stable graft function and normal biopsy results.",
keywords = "Gene expression, HIV, Kidney transplantation, Tacrolimus",
author = "Thangamani Muthukumar and Cheguevara Afaneh and Ruchuang Ding and Demetra Tsapepas and Michelle Lubetzky and Samantha Jacobs and John Lee and Vijay Sharma and Jun Lee and Darshana Dadhania and Choli Hartono and Jennifer McDermott and Meredith Aull and David Leeser and Sandip Kapur and David Serur and Manikkam Suthanthiran",
year = "2013",
month = "3",
day = "15",
doi = "10.1097/TP.0b013e31827ac322",
language = "English",
volume = "95",
pages = "711--720",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol

T2 - Clinical outcomes and messenger RNA profiles

AU - Muthukumar, Thangamani

AU - Afaneh, Cheguevara

AU - Ding, Ruchuang

AU - Tsapepas, Demetra

AU - Lubetzky, Michelle

AU - Jacobs, Samantha

AU - Lee, John

AU - Sharma, Vijay

AU - Lee, Jun

AU - Dadhania, Darshana

AU - Hartono, Choli

AU - McDermott, Jennifer

AU - Aull, Meredith

AU - Leeser, David

AU - Kapur, Sandip

AU - Serur, David

AU - Suthanthiran, Manikkam

PY - 2013/3/15

Y1 - 2013/3/15

N2 - Background. The outcome of HIV-infected kidney transplant recipients managed with an early corticosteroid withdrawal protocol is not known. Methods. Eleven consecutive HIV-infected patients with undetectable plasma HIV RNA and more than 200/mm3 CD4+ T cells underwent deceased-donor (n=8) or living-donor (n=3) kidney transplantation at our center. All were managed with an early corticosteroid withdrawal protocol; 9 of 11 received antithymocyte globulin and 2 received basiliximab induction. We analyzed patient and graft outcomes, acute rejection rate, HIV progression, BKV replication, infections, and urinary cell mRNA profiles. Results. The median (range) follow-up was 44.5 (26Y73) months. The incidence of acute rejection was 9% at 1 year and the patient and allograft survival rates were 100% and 91%, respectively. Estimated glomerular filtration rate at 1 year (meanTSD) was 78T39 mL/min/1.73 m2. Plasma HIV RNA was undetectable at 24 months and none had BKV replication. Six of the 11 kidney recipients developed eight infections requiring hospitalization. Urinary cell levels of mRNA for complement components and complement regulatory proteins, cell lineageYspecific proteins CD3, CD4, CD8, CTLA4, Foxp3, chemokine IP-10, cytotoxic perforin and granzyme B, and BKV VP1 mRNA were not different (P90.05) between HIV-infected patients and HIV-negative recipients (n=22) with stable graft function and normal biopsy results. Conclusion. An early steroid withdrawal regimen with antithymocyte globulin induction was associated with excellent graft and patient outcomes in HIV-infected recipients of kidney allografts. Their urinary cell mRNA profiles are indistinguishable from those of HIV-negative patients with stable graft function and normal biopsy results.

AB - Background. The outcome of HIV-infected kidney transplant recipients managed with an early corticosteroid withdrawal protocol is not known. Methods. Eleven consecutive HIV-infected patients with undetectable plasma HIV RNA and more than 200/mm3 CD4+ T cells underwent deceased-donor (n=8) or living-donor (n=3) kidney transplantation at our center. All were managed with an early corticosteroid withdrawal protocol; 9 of 11 received antithymocyte globulin and 2 received basiliximab induction. We analyzed patient and graft outcomes, acute rejection rate, HIV progression, BKV replication, infections, and urinary cell mRNA profiles. Results. The median (range) follow-up was 44.5 (26Y73) months. The incidence of acute rejection was 9% at 1 year and the patient and allograft survival rates were 100% and 91%, respectively. Estimated glomerular filtration rate at 1 year (meanTSD) was 78T39 mL/min/1.73 m2. Plasma HIV RNA was undetectable at 24 months and none had BKV replication. Six of the 11 kidney recipients developed eight infections requiring hospitalization. Urinary cell levels of mRNA for complement components and complement regulatory proteins, cell lineageYspecific proteins CD3, CD4, CD8, CTLA4, Foxp3, chemokine IP-10, cytotoxic perforin and granzyme B, and BKV VP1 mRNA were not different (P90.05) between HIV-infected patients and HIV-negative recipients (n=22) with stable graft function and normal biopsy results. Conclusion. An early steroid withdrawal regimen with antithymocyte globulin induction was associated with excellent graft and patient outcomes in HIV-infected recipients of kidney allografts. Their urinary cell mRNA profiles are indistinguishable from those of HIV-negative patients with stable graft function and normal biopsy results.

KW - Gene expression

KW - HIV

KW - Kidney transplantation

KW - Tacrolimus

UR - http://www.scopus.com/inward/record.url?scp=84877280147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877280147&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e31827ac322

DO - 10.1097/TP.0b013e31827ac322

M3 - Article

VL - 95

SP - 711

EP - 720

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 5

ER -